Eli Lilly has filed 6 lawsuits against companies allegedly selling unapproved versions of investigational obesity drug retatrutide, highlighting growing legal and regulatory scrutiny of unauthorized products entering the rapidly expanding...
Eli Lilly has filed 6 lawsuits against companies allegedly selling unapproved versions of investigational obesity drug retatrutide, highlighting growing legal and regulatory scrutiny of unauthorized products entering the rapidly expanding...
The Arkansas State Board of Pharmacy has suspended enforcement of a law restricting manufacturers' use of limited drug distribution networks after a federal court found the statute likely violates the dormant Commerce Clause, setting up a...
The Arkansas State Board of Pharmacy has suspended enforcement of a law restricting manufacturers' use of limited drug distribution networks after a federal court found the statute likely violates the dormant Commerce Clause, setting up a...
EyePoint Pharmaceuticals has agreed to pay $4.6 million to resolve False Claims Act allegations involving DEXYCU marketing practices, highlighting continued federal scrutiny of pharmaceutical manufacturer programs under the Anti-Kickback...
EyePoint Pharmaceuticals has agreed to pay $4.6 million to resolve False Claims Act allegations involving DEXYCU marketing practices, highlighting continued federal scrutiny of pharmaceutical manufacturer programs under the Anti-Kickback...
A Florida laboratory agreed to pay $9.8 million to resolve False Claims Act (FCA) allegations involving physician compensation arrangements that allegedly violated the Stark Law, highlighting ongoing federal scrutiny of referral-based...
A Florida laboratory agreed to pay $9.8 million to resolve False Claims Act (FCA) allegations involving physician compensation arrangements that allegedly violated the Stark Law, highlighting ongoing federal scrutiny of referral-based...
The Federal Trade Commission's (FTC) proposed settlement with CVS Caremark would require significant changes to pharmacy benefit manager (PBM) rebate practices, transparency, formulary management, and pharmacy contracting, signaling evolving...
The Federal Trade Commission's (FTC) proposed settlement with CVS Caremark would require significant changes to pharmacy benefit manager (PBM) rebate practices, transparency, formulary management, and pharmacy contracting, signaling evolving...
Former executives of Done Global were sentenced to federal prison after convictions in a multimillion-dollar scheme involving unlawful telehealth prescribing of Adderall and health care fraud, according to the US Department of Justice.
Former executives of Done Global were sentenced to federal prison after convictions in a multimillion-dollar scheme involving unlawful telehealth prescribing of Adderall and health care fraud, according to the US Department of Justice.
A US Department of Justice (DOJ) enforcement action against a telemedicine company owner underscores continuing regulatory scrutiny of telemedicine prescribing, kickback arrangements, and Medicare billing practices.
A US Department of Justice (DOJ) enforcement action against a telemedicine company owner underscores continuing regulatory scrutiny of telemedicine prescribing, kickback arrangements, and Medicare billing practices.
The Pharmaceutical Care Management Association has sued Illinois to block key provisions of the state's Prescription Drug Affordability Act, setting up a legal challenge that could shape the future of pharmacy benefit manager (PBM)...
The Pharmaceutical Care Management Association has sued Illinois to block key provisions of the state's Prescription Drug Affordability Act, setting up a legal challenge that could shape the future of pharmacy benefit manager (PBM)...
Ahold Delhaize USA agreed to pay $40 million to resolve allegations that supermarket pharmacies reported inflated usual and customary drug prices to federal health care programs.
Ahold Delhaize USA agreed to pay $40 million to resolve allegations that supermarket pharmacies reported inflated usual and customary drug prices to federal health care programs.
